Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
5
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
US Stock MarketDetailed Quotes
Xeris Pharmaceuticals (XERS)
- 6.180
- +0.030+0.49%
Close Jun 5 15:59 ET
1.07BMarket Cap84.66P/E (TTM)
6.255High6.103Low1.06MVolume6.170Open6.150Prev Close6.55MTurnover0.65%Turnover Ratio2060.00P/E (Static)172.64MShares10.08052wk High82.40P/B1.01BFloat Cap4.35552wk Low--Dividend TTM163.84MShs Float27.983Historical High--Div Yield TTM2.47%Range %0.970Historical Low6.190Avg Price1Lot Size
Xeris Pharmaceuticals (XERS) Key Financial Indicators
XERS Earnings per Share (EPS)
According to the latest financial report of Xeris Pharmaceuticals, the latest earnings per share (TTM) for the company is 0.01. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
XERS Free Cash Flow (FCF)
Interested in knowing about Xeris Pharmaceuticals's free cash flow? The latest report shows it as 9.55M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
XERS Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Xeris Pharmaceuticals shows that the company's current ratio is 2.12, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
XERS Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Xeris Pharmaceuticals, the quick ratio is 1.42, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
XERS Return on Equity (ROE)
Want to learn more about the financial health of Xeris Pharmaceuticals? The latest ROE figure is 16.73%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
XERS Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Xeris Pharmaceuticals, the total asset return on investment (ROA) is 0.58%.
Currency: USD
Quarterly
Loading...
XERS Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Xeris Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at 87.28%.
Currency: USD
Quarterly
Loading...
XERS Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Xeris Pharmaceuticals, the net profit margin is 2.69%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Over the weekend, Iran launched missiles at Israel again—its first such strike in two months following the April 8 ceasefire between the U.S
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm